Kenji Watanabe

18PUBLICATIONS
89CO-AUTHORS
Clinical chemistry (incl. diagnostics)GlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 08, 2026
Safety and effectiveness of carotegrast methyl in patients with ulcerative colitis: an interim report of post-marketing surveillance in Japan.

|Sep 28, 2026
Effectiveness, safety, and clinical outcomes of treatment with the oral α4-integrin antagonist carotegrast methyl in patients with active ulcerative colitis: a multicenter observational study (CANAL study).

|Aug 04, 2024
Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.

Kenji Watanabe, Fumihito Hirai, Kiyonori Kobayashi

|Nov 29, 2023
Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.

Kenji Watanabe, Laurent Peyrin-Biroulet, Silvio Danese

|Aug 10, 2023
Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT.

Kenji Watanabe, Masanori Nojima, Hiroshi Nakase

|Mar 04, 2023
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD).

Takayuki Yamamoto, Hiroshi Nakase, Kenji Watanabe

Pageof 3

Frequent Collaborators

6 joint publications

Fumihito Hirai

5 joint publications

Hiroshi Nakase

4 joint publications

Makoto Naganuma

4 joint publications

Katsuyoshi Matsuoka